The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19

Saved in:
Bibliographic Details
Published inInternational journal of infectious diseases Vol. 100; pp. 25 - 26
Main Authors Sadasivam, Balakrishnan, Atal, Shubham, Ray, Avik, Sharma, Swati
Format Journal Article
LanguageEnglish
Published Canada Elsevier Ltd 01.11.2020
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases
Elsevier
Subjects
Betacoronavirus
Coronavirus Infections - drug therapy
COVID-19
Dust
Humans
Hydroxychloroquine - adverse effects
Letter to the Editor
Pandemics
Pneumonia, Viral
SARS-CoV-2
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
ObjectType-Commentary-2
content type line 23
ISSN:1201-9712
1878-3511
1878-3511
DOI:10.1016/j.ijid.2020.08.058